SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 258.92 |
| Enterprise Value ($M) | 259.22 |
| Book Value ($M) | -9.16 |
| Book Value / Share | -0.38 |
| Price / Book | -28.27 |
| NCAV ($M) | -258.92 |
| NCAV / Share | -10.88 |
| Price / NCAV | -1.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.36 |
| Current Ratio | 0.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.28 |
| Assets | 250.04 |
| Liabilities | 259.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -0.94 |
| Net Income | 11.32 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -0.42 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.32 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vivaldi Asset Management, LLC | 8.61 | 62.59 | |
| 13G | Fort Baker Capital Management LP | 5.51 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,111 | 6,454 | 17.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EBS – Emergent BioSolutions Inc. | ELAN – Elanco Animal Health Incorporated |
| ENZ – Enzo Biochem, Inc. | JNJ – Johnson & Johnson |
| LLY – Eli Lilly and Company |
Financial data and stock pages provided by
Fintel.io